Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.62
- Piotroski Score 6.00
- Grade N/A
- Symbol (TCI)
- Company Transcontinental Realty Investors, Inc.
- Price $27.49
- Changes Percentage (-3.24%)
- Change -$0.92
- Day Low $27.20
- Day High $28.40
- Year High $43.40
Transcontinental Realty Investors, Inc., a Dallas-based real estate investment company, holds a diverse portfolio of equity real estate located across the U.S., including apartments, office buildings, shopping centers, and developed and undeveloped land. The Company invests in real estate through direct ownership, leases and partnerships and invests in mortgage loans on real estate.
- Last Earnings 09/12/2000
- Ex-Dividend for 5/16 Dividend 09/15/2000
- Dividend Payable 09/29/2000
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.58
- Trailing P/E Ratio 49.72
- Forward P/E Ratio 49.72
- P/E Growth 49.72
- Net Income $5.94 M
Income Statement
Quarterly
Annual
Latest News of TCI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
Intra-Cellular Therapies' shares surged 14% after its latest quarterly results, with analysts forecasting a 52% revenue increase by 2025. Earnings per share are expected to rise, indicating a bullish ...
By Yahoo! Finance | 5 days ago -
TCI Express Ltd (NSE:TCIEXP) Q2 2025 Earnings Call Highlights: Navigating Challenges with ...
Branch expansion is temporarily paused due to low volume. Air Express costs impacted Q2 margins; unable to pass on costs. Expect 13-15% volume growth in 2-3 years. Industries affecting growth include ...
By Yahoo! Finance | 1 week ago -
Intra-Cellular Therapies, Inc. (ITCI): Among the Most Promising Mid-Cap Stocks According to Hedge Funds
The article discusses the top mid-cap stocks favored by hedge funds, focusing on Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), ranking 8th....
By Yahoo! Finance | 3 weeks ago
